Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
Conventional antiarrhythmic drugs are an important tool for the clinical cardiologist for the treatment of ventricular arrhythmias. Knowledge of the different properties of these drugs will help decrease the incidence of adverse effects and increase the frequency of successful therapy.
D000889:Anti-Arrhythmia Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001950:Bretylium Tosylate / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D006352:Heart Ventricles; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D016677:Tocainide
D000889:Anti-Arrhythmia Agents; D016677:Tocainide; D001950:Bretylium Tosylate; D008012:Lidocaine; D011433:Propranolol; D004206:Disopyramide; D011802:Quinidine; D011342:Procainamide